c-MET amplification upregulated PD-L1 expression in EGFR-TKI resistant... | Download Scientific Diagram
MET Signaling: Novel Targeted Inhibition and Its Clinical Development in Lung Cancer - ScienceDirect
The role of MET in chemotherapy resistance | Oncogene
MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer | Journal of Hematology & Oncology | Full Text
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling | Science
An overview of the c-MET signaling pathway - Shawna Leslie Organ, Ming-Sound Tsao, 2011
The multiple paths towards MET receptor addiction in cancer | Oncogene
Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?
Frontiers | The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy
Chidamide increases the sensitivity of Non-small Cell Lung Cancer to Crizotinib by decreasing c-MET mRNA methylation
Nanoscale Mapping of EGFR and c-MET Protein Environments on Lung Cancer Cell Surfaces via Therapeutic Antibody Photocatalyst Conjugates | ACS Chemical Biology
Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy | Nature Reviews Cancer
Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification - Annals of Oncology
CytoCell C-MET (MET) Amplification FISH Probe | OGT
The promise of selective MET inhibitors in non-small cell lung cancer with MET exon 14 skipping - Cancer Treatment Reviews
MET-dependent solid tumours — molecular diagnosis and targeted therapy | Nature Reviews Clinical Oncology
Imugex
Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer | Molecular Cancer | Full Text
Targeting MET in Cancer: Obstacles and Potentials
c-MET
Frontiers | Crosstalk Mechanisms Between HGF/c-Met Axis and ncRNAs in Malignancy
Figure 1 from MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression. | Semantic Scholar
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752 | PNAS
The METeoric rise of MET in lung cancer - Friedlaender - 2020 - Cancer - Wiley Online Library
